Cargando…
Canadian Association of Gastroenterology Statement on the Putative Link Between Proton Pump Inhibitor Treatment and Gastric Cancer after Helicobacter pylori Eradication
Autores principales: | Leontiadis, Grigorios I, Veldhuyzen Van Zanten, Sander, Hookey, Lawrence, Armstrong, David, Jones, Nicola, Moayyedi, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542241/ https://www.ncbi.nlm.nih.gov/pubmed/31294357 http://dx.doi.org/10.1093/jcag/gwy040 |
Ejemplares similares
-
Joint Canadian Association of Gastroenterology and Crohn’s Colitis Canada Position Statement on Biosimilars for the Treatment of Inflammatory Bowel Disease
por: Moayyedi, Paul, et al.
Publicado: (2019) -
Canadian Association of Gastroenterology (CAG) Position Statement on the Use of Hyoscine-n-butylbromide (Buscopan) During Gastrointestinal Endoscopy
por: Forbes, Nauzer, et al.
Publicado: (2021) -
COVID-19 Vaccination in Patients With Inflammatory Bowel Disease: Communiqué From the Canadian Association of Gastroenterology
por: Tse, Frances, et al.
Publicado: (2021) -
COVID-19: Advice from the Canadian Association of Gastroenterology for Endoscopy Facilities, as of March 16, 2020
por: Tse, Frances, et al.
Publicado: (2020) -
Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease
por: Moayyedi, Paul, et al.
Publicado: (2020)